Navigation Links
Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Date:12/7/2012

CARLSBAD, Calif., Dec. 7, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from Phase 1 studies of three drugs, ISIS-PTP1BRx, ISIS-GCGRRx and ISIS-GCCRRx, in development to treat metabolic disorders, including type 2 diabetes.  In all three Phase 1 studies, the drugs were safe and well tolerated with early encouraging data that supports the unique mechanism of each drug. All three drugs are part of Isis' metabolic franchise and are designed to act through distinct mechanisms to improve insulin sensitivity and/or reduce glucose production. 

"Our goal is to develop safe, effective drugs with unique mechanisms of action that can provide significant therapeutic benefit for patients with metabolic disorders, including type 2 diabetes. This year we have moved closer to this goal with the completion of our initial clinical studies on three promising drugs from our metabolic franchise.  These drugs are uniquely positioned to fill the critical voids in diabetes therapy," said Stanley T. Crooke, M.D., Ph.D., chief executive officer at Isis.  "While these drugs may be beneficial as single agents, our goal is to develop them as adjuncts to existing diabetes therapies.  We believe that each drug has the potential to address a distinct and significant commercial market in patients with type 2 diabetes."

ISIS-PTP1BRx
ISIS-PTP1BRx targets protein tyrosine phosphatase-1B (PTP-1B) and is designed to increase the body's sensitivity to insulin, resulting in better glucose control for patients with type 2 diabetes.  Because of its unique mechanism, ISIS-PTP1BRx has the potential to help patients achieve glucose control without weight gain or hypoglycemia.  In the Phase 1 study of ISIS-PTP1BRx in obese healthy volunteers, I
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
3. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
5. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
6. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
7. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
8. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
9. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
10. Cadence Pharmaceuticals to Host Analyst and Investor Day
11. Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... DIEGO , Nov. 25, 2014 Halozyme Therapeutics, ... the Piper Jaffray Healthcare Conference in New York ... EDT/10:00 a.m. PDT . Dr. Helen Torley , ... The presentation will be webcast through the "Investors" ... a recording will be made available for 90 days following ...
(Date:11/24/2014)... Nov. 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... a corporate overview and update at the Piper Jaffray 26 ... at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), at ... . A live audio webcast of the ... Arena,s website at www.arenapharm.com . A replay of the ...
(Date:11/24/2014)... -- Marta Rendon, MD, founder of the Rendon Center for Dermatology ... international key opinion leader in dermatology, was one of only ... to attend the international Aesthetic Experts Summit held ... at this gathering of over 600 physicians from 57 countries, ... experts from Asia and ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... Alcona Health Center is one of the first organizations ... payment after successfully meeting the requirements for Year One ... Alcona Health received a first-year incentive payment for each ... Medicare and Medicaid Services, resulting in one of the ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), ... that Jeffrey H. Burbank, Chief Executive Officer, will present ... September 20th, at 3:00 p.m. ET.   A webcast ... http://www.nxstage.com/ir.cfm at the time of the presentation. ...
Cached Medicine Technology:SuccessEHS Client Among First in State of Michigan to Receive Medicaid Stimulus Funds 2SuccessEHS Client Among First in State of Michigan to Receive Medicaid Stimulus Funds 3SuccessEHS Client Among First in State of Michigan to Receive Medicaid Stimulus Funds 4
(Date:11/26/2014)... November 26, 2014 Call 866-997-4948 (Us-Canada ... or email the details on sales(at)researchmoz(dot)us , Researchmoz.us ... drug discovery market 2014" with deep study of the ... result of high blood sugar. The global glucose monitoring ... to the growing number of diabetics in the world. ...
(Date:11/26/2014)... Lenexa, Kansas (PRWEB) November 26, 2014 ... will showcase expanded capabilities at RSNA 2014 ... capture, access, manage and share diagnostic images, photos, ... Visitors to Perceptive’s booth #8107 will learn more ... including newly acquired technologies and partner initiatives – ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Parents need to ... sports concussions, an expert warns. Parents must make ... undergo standard, Dr. David Dodick, chair of the American ... Mayo Clinic College of Medicine in Scottsdale, Ariz. in ... news release. Any coach involved with teens sports ...
(Date:11/24/2014)... The Mesothelioma Applied Research Foundation ... Symposium on Malignant Mesothelioma from March 2nd through March ... will take place on the campus of the National ... community dinner and an awards ceremony, will be held ... a range of topics about pleural and peritoneal mesothelioma, ...
Breaking Medicine News(10 mins):Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 3
... Consultancy to Address Circle of Patient Care, ... Mike Marolt, president of St.,Paul-based eq-life(R), announced ... to provide pharmacy operations consulting to,hospital organizations ... a,multi-year agreement with Omaha-based Alegent Health to ...
... Satisfaction and Other ... Areas, ... first Hospital Consumer Assessment of Healthcare Providers and,Systems (HCAHPS) scores for hospitals ... for Special Surgery,(HSS) in New York City scored well above the national ...
... progestin effectively suppressed sperm production , , FRIDAY, March ... and progestin suppresses sperm production faster and more ... by an international team of researchers. , The ... safe, effective and reversible form of male birth ...
... stem cells to be engineered into new blood vessels or ... the hair on their patients heads, according to new research ... , Engineering blood vessels for bypass surgery, promoting the ... using stem cells obtained from the most accessible source -- ...
... Caregivers at Catholic Facilities Join Union, LOS ... an overwhelming majority of healthcare workers at St. ... Medical Foundation health clinics in,the Sacramento area voted ... Workers-West (UHW)., "This victory shows we,re united," ...
... However, patients stay on the new medications longer, study ... so-called second-generation antipsychotics are no better than the older ... a new study finds. , However, it appears that ... likely to continue using them than haloperidol, the study ...
Cached Medicine News:Health News:eq-life(R) and Fairview Pharmacy Services Announce Multi-Year Consulting Contract with Alegent Health 2Health News:eq-life(R) and Fairview Pharmacy Services Announce Multi-Year Consulting Contract with Alegent Health 3Health News:Hospital for Special Surgery Reports Scores on HCAHPS Survey 2Health News:Hospital for Special Surgery Reports Scores on HCAHPS Survey 3Health News:Hormone Combo May Provide Reversible Male Birth Control Tool 2Health News:Stem cells from hair follicles may help 'grow' new blood vessels 2Health News:Healthcare Workers Across California Vote to Join UHW 2Health News:New Drugs No Better Than Older Ones for Schizophrenia 2Health News:New Drugs No Better Than Older Ones for Schizophrenia 3
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... offers a complete line of flowmeters, ... CO 2 . They are all ... to best suit your application. With ... to the gas in use, the ...
Medicine Products: